Merck & Co is a general drug manufacturer company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker MRK on the NYSE exchange.
Merck & Co stock last closed at $148.30, up 1.07% from the previous day, and has increased 71.06% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.39 percentage points. Merck & Co stock is currently +80.83% from its 52-week low of $82.01, and -5.49% from its 52-week high of $156.92.
As of Oct 20, 2026, there are 2.47B MRK shares outstanding. The market cap of MRK is $365.88B. In the past 24 hours, 9.92M MRK shares were traded.
You need a brokerage account in order to access the NYSE market and buy MRK shares.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal details so you are able to invest in MRK today.
Now that you've opened your account on the best app for stock investing, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new brokerage account.
After you have figured out the best place to buy Merck & Co stock, it's critical to research their stock before you buy, so you can comprehend the risk and opportunity.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on MRK's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge MRK's true value.
Using relative valuations ratios:
You can do additional valuation research on MRK's stock here.
Out of 17 sell side analysts who give ratings on MRK, the consensus analyst rating on Merck & Co is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Louise Chen, a top 11% analyst from ScotiaBank maintains MRK with a buy rating and raises their MRK price target from $155.00 to $180.00, on Sep 29, 2026.
Rajesh Kumar, a top 29% analyst from HSBC maintains MRK with a strong buy rating and raises their MRK price target from $150.00 to $172.00, on Sep 10, 2026.
Daina Graybosch, a bottom 1% analyst from Leerink Partners maintains MRK with a buy rating and raises their MRK price target from $127.00 to $161.00, on Sep 9, 2026.
Vamil Divan, a top 4% analyst from Guggenheim maintains MRK with a strong buy rating and raises their MRK price target from $146.00 to $170.00, on Sep 8, 2026.
Guggenheim's Vamil Divan raised their price target on Merck & Co (NYSE: MRK) by 16.4% from $146 to $170 on 2026/09/08. The analyst maintained their Strong Buy rating on the stock.
Divan attributed their price target hike on Guggenheim's Biopharma Top Pick Merck to increased sales estimates for intismeran autogene following "historic" positive topline data the company and partner Moderna released for that asset in patients with stage IIB-IV melanoma.
Mohit Bansal, a top 12% analyst from Wells Fargo maintains MRK with a strong buy rating and raises their MRK price target from $150.00 to $170.00, on Sep 4, 2026.
You can dig deeper into what analysts are projecting on the Merck & Co stock forecast page.
Last year, MRK earnings were $3.17B. Over the last five year, MRK's earnings have increased by -10.41% per year. This was slower than the Drug Manufacturers - General industry average of 11.42%.
Last year, MRK revenue was $66.57B. Over the past 5 year, MRK's revenue has grown by 8.68% per year. This was slower than the Drug Manufacturers - General industry average of 10.61%.
You can research MRK's earnings and revenue performance here.
In the past year, insiders at MRK have sold more shares than they have bought.
Chirfi Guindo, EVP of MRK, was the latest MRK insider to sell. They sold $1,350,000.00 worth of MRK shares on Aug 13, 2026.
Get more info about who owns MRK stock here.
Merck & Co pays a dividend of 2.29%, compared to the Drug Manufacturers - General industry's average dividend yield of 2.57%. If you owned $1,000 of MRK stock, you would have received $22.93 last year.
Merck & Co dividend payments have consistently grown over the past decade and have remained stable.
Dig into more data about Merck & Co dividend yield and history here.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
There are two main options:
Click the Open button and eToro will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in MRK, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to track the latest developments regarding your MRK stock.
To summarize, here are the 6 steps you need to take to buy Merck & Co stock right now:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Merck & Co, click the button below.